Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Paul Kouéhion"'
Autor:
Tolo Diebkilé Aïssata, Duni Sawadogo, Clotaire Nanho, Boidy Kouakou, N'dogomo Meité, N'Dhatz Emeuraude, Ayémou Roméo, Sekongo Yassongui Mamadou, Paul Kouéhion, Konan Mozart, Gustave Koffi, Ibrahima Sanogo
Publikováno v:
Advances in Hematology, Vol 2013 (2013)
Imatinib mesylate provides good results in the treatment of CML in general. But what about the results of this treatment in CML associated with additional cytogenetic abnormalities at diagnosis among black Africans? For this, we retrospectively studi
Externí odkaz:
https://doaj.org/article/c18279b347dd4b068ba9aa4c68e20918
Autor:
Diebkilé Aïssata Tolo, Duni Sawadogo, Danho Clotaire Nanho, Boidy Kouakou, N’Dogomo Méité, Roméo Ayémou, Paul Kouéhion, Mozart Konan, Yassongui Mamadou Sékongo, Emeraude N’Dhatz, Ismaël Kamara, Alexis Silué, Kouassi Gustave Koffi, Ibrahima Sanogo
Publikováno v:
Advances in Hematology, Vol 2013 (2013)
We retrospectively studied 30 cases of multiple myeloma in patients under the age of 65, diagnosed from 1991 to 2005 in the clinical hematology department of the University Hospital of Yopougon that is a hospital incidence of 2.9 cases/year. The age
Externí odkaz:
https://doaj.org/article/d5c833ccb28f41de8dc86afe373d821f
Autor:
Aïssata Tolo Diebkilé, Boidy Kouakou, Emeraude N'dhatz, Clotaire D. Nanho, N'Dogomo Meité, Roméo Ayémou, Mamadou Y. Sekongo, Paul Kouéhion, Mozart Konan, Gustave K. Koffi, Ibrahima Sanogo
Publikováno v:
Advances in Hematology, Vol 2012 (2012)
Diffuse large B-cell lymphomas have been little studied in black Africans. The purpose of our study was to determine the characteristics and results of the management of these lymphomas. Patients and Methods. In a descriptive and analytic retrospecti
Externí odkaz:
https://doaj.org/article/78d8fe31a88847e3ba44a7dc1ada0f31
Autor:
Amadou Sangaré, Emeraude N’dathz, Mori Meité, Aissata Tolo, Romeo Ayemou, Boidy Kouakou, Mamadou Y. Sekongo, Paul Kouéhion, Ibrahima Sanogo, D C Nanho, Mathias Yao Kouassi, Fatou Diago N’Diaye, N'Dogomo Meité, Norbert Dagnekpo Tea, Gustave Koffi
Publikováno v:
International Journal of Hematology. 91:838-843
African Burkitt lymphomas (BL) are highly aggressive lymphomas mainly affecting children and young adults in Africa. This lymphoma was marked by its high sensitivity to chemotherapy in comparison to Sporadic Burkitt lymphoma. In this study, we evalua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee8567078c0d99d6c62ad26ce527c538
https://doi.org/10.1007/s12185-010-0591-z
https://doi.org/10.1007/s12185-010-0591-z
Autor:
N'Dogomo Meité, Paul Kouéhion, Ibrahima Sanogo, Kouassi Gustave Koffi, D C Nanho, Emeraude N’dathz, Aissata Tolo, Romeo Ayemou
Publikováno v:
Cahiers de Santé. 20:69-72
In this retrospective study, we analysed rare localisations of Burkitt lymphoma observed in the Haematology Department of the University Hospital of Yopougon Abidjan. Over a 10-year study period, we saw 106 patients with Burkitt lymphoma, 21 with unu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81559fb087f14c05a42fb47c1c826d6a
https://doi.org/10.1684/san.2010.0196
https://doi.org/10.1684/san.2010.0196
Autor:
Paul Kouéhion, Emeraude N’dathz, Aissata Tolo, Romeo Ayemou, Mamadou Y. Sekongo, K. Boidy, D C Nanho, Ibrahima Sanogo, N'Dogomo Meité, K. Mozard, Kouassi Gustave Koffi, A. K Attia, R. Dissieka, N. Tea
Publikováno v:
Advances in Hematology, Vol 2010 (2010)
Advances in Hematology
Advances in Hematology
Imatinib mesylate, showed encouraging activity in chronic myelogenous leukemia. However, there are few data regarding his efficacy and response monitoring in Sub-Saharan African patients. Our objective was to assess response to imatinib mesylate (Gli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8154ec14dbcc1f07ac2e06cb699f87f3
https://doi.org/10.1155/2010/268921
https://doi.org/10.1155/2010/268921
Autor:
Paul Kouéhion, Romeo Ayemou, N'Dogomo Meité, Diebkilé Aïssata Tolo, Boidy Kouakou, Ismael Kamara, Mozart Konan, Duni Sawadogo, Yassongui Mamadou Sekongo, Ibrahima Sanogo, Kouassi Gustave Koffi, Alexis Dohoma Silue, D C Nanho, Emeraude N'dhatz
Publikováno v:
Advances in Hematology, Vol 2013 (2013)
Advances in Hematology
Advances in Hematology
We retrospectively studied 30 cases of multiple myeloma in patients under the age of 65, diagnosed from 1991 to 2005 in the clinical hematology department of the University Hospital of Yopougon that is a hospital incidence of 2.9 cases/year. The age
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::710c22b9a1cb26d4b98531a3dba79776
https://doaj.org/article/d5c833ccb28f41de8dc86afe373d821f
https://doaj.org/article/d5c833ccb28f41de8dc86afe373d821f
Autor:
Gustave Koffi, Ibrahima Sanogo, Paul Kouéhion, Clotaire Danho Nanho, Sekongo Yassongui Mamadou, Boidy Kouakou, N'Dogomo Meité, Duni Sawadogo, Ayémou Roméo, Konan Mozart, N’Dhatz Emeuraude, Tolo Diebkilé Aïssata
Publikováno v:
Advances in Hematology
Advances in Hematology, Vol 2013 (2013)
Advances in Hematology, Vol 2013 (2013)
Imatinib mesylate provides good results in the treatment of CML in general. But what about the results of this treatment in CML associated with additional cytogenetic abnormalities at diagnosis among black Africans? For this, we retrospectively studi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e60049f265243f6f961ed8927da116ac
Autor:
Paul Kouéhion, Aïssata Tolo Diebkilé, Emeraude N'dhatz, Romeo Ayemou, Mamadou Y. Sekongo, N'Dogomo Meité, Ibrahima Sanogo, Boidy Kouakou, Gustave Koffi, Clotaire Danho Nanho, Mozart Konan
Publikováno v:
Advances in Hematology
Advances in Hematology, Vol 2012 (2012)
Advances in Hematology, Vol 2012 (2012)
Diffuse large B-cell lymphomas have been little studied in black Africans. The purpose of our study was to determine the characteristics and results of the management of these lymphomas. Patients and Methods. In a descriptive and analytic retrospecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d2781fac120129ddbbbb91b05ef23cf
https://pubmed.ncbi.nlm.nih.gov/22693514
https://pubmed.ncbi.nlm.nih.gov/22693514
Autor:
GUSTAVE Kouassi KOFFI, Alain Attia, Emeraude N'dahtz, Clotaire Nanho, Romance Dissieka, Aissata Tolo, Paul Kouehion, Mozard Konan, Boidy Kouakou, N'dogomo Meité, Romeo Ayemou, Yassongui Sekongo, Norbert Tea, Ibrahima Sanogo
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 1 (2014)
Objective: Imatinib mesylate has shown encouraging activity in chronic myelogenous leukemia (CML). However, to the best of our knowledge, there are few data regarding imatinib efficacy and response monitoring in Sub-Saharan African patients. Our obje
Externí odkaz:
https://doaj.org/article/01bcbb4cfffd42b1ae92e930f9fc3110